Clinical Trial Update: Intravenous N-Acetylcysteine for the Treatment of Acute Ischemic Stroke [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating intravenous N-acetylcysteine for acute ischemic stroke has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | Conditions: Acute Ischemic Stroke | Phase 2 | Status: COMPLETED